HER2 inhibitors (Xavier University of Louisiana/Tulane University)

N/A

Report date: 2025/01/26 18:29:14
NME

Base Information

Drug NameHER2 inhibitors (Xavier University of Louisiana/Tulane University)
Drug Alias NameRLS-77
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionReceptor protein-tyrosine kinase erbB-2 antagonists
TargetsReceptor protein-tyrosine kinase erbB-2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesXavier University Of Louisiana.
China Registration ClassN/A

Develop Information

Active CompaniesXavier University Of Louisiana.Tulane University
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A